ACRESTA
Acresta is a global software, technology and services provider with headquarters in Sydney, Australia and offices in Melbourne, Auckland, Singapore, the Philippines and Vietnam delivering innovative business software solutions to meet the needs of today’s enterprises and the environment in which they operate. They are proud to be an industry leader in the provision of customised, agile environmental software and mobile solution platforms.
ACRESTA
Industry:
Information Technology Software
Founded:
2009-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.acresta.com
Total Employee:
11+
Status:
Closed
Contact:
+61 2 8208 3366
Email Addresses:
[email protected]
Technology used in webpage:
Amazon Nginx YouTube Apple Mobile Web App Capable Common Name Invalid ASP.NET IIS CloudFront IIS 10 Apple Mobile Web App Status Bar Style
Similar Organizations
Cloud Seven
Cloud Seven is an ICT firm that deals in Enterprise Mobility and innovation.
Crescent Info Soft
Crescent Info Soft is an innovative Business Solutions provider and a thought leader in Enterprise Mobility, Enterprise Integration.
Express Mobile
Express Mobile is a technology company that specializes in developing enterprise mobility solutions.
Newest Events participated
Participated in Gartner Symposium/ITxpo Gold Coast 2016
on 2016-10-24 as exhibitor
Official Site Inspections
http://www.acresta.com
- Host name: ec2-54-252-131-106.ap-southeast-2.compute.amazonaws.com
- IP address: 54.252.131.106
- Location: Sydney Australia
- Latitude: -33.8591
- Longitude: 151.2002
- Timezone: Australia/Sydney
- Postal: 2000
More informations about "Acresta"
Alcresta Therapeutics
Alcresta develops rare disease, enzyme-based products helping to address fat malabsorption (often due to exocrine pancreatic insufficiency) in patients who are enterally fed at home or in the hospital. Our RELiZORB ® cartridge contains …See details»
Alcresta - Crunchbase Company Profile & Funding
Alcresta’s research-based approach is innovative, proprietary and driven by the unmet nutritional needs of those people with compromised health. Alcresta’s core capabilities include expertise …See details»
Alcresta Therapeutics Company Profile | Management and
Alcresta currently markets RELiZORB for enterally fed patients with pancreatic insufficiency, which occurs in cystic fibrosis, pancreatic cancer, and pancreatitis, and is developing platfor m …See details»
Alcresta Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Alcresta Therapeutics, Inc. of Waltham, MA. Get the latest business insights from Dun & Bradstreet.See details»
Alcresta Therapeutics - LinkedIn
Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare ...See details»
Alcresta Therapeutics Company Profile 2024: Valuation, …
Alcresta Therapeutics General Information Description. Developer of enzyme-based products designed to combat gastrointestinal disorders. The company's digestive enzyme cartridge has been designed to mimic the function of …See details»
Alcresta - Funding, Financials, Valuation & Investors - Crunchbase
Alcresta is funded by 4 investors. HealthQuest Capital and Bessemer Venture Partners are the most recent investors. Alcresta has a post-money valuation in the range of $100M to $500M …See details»
Acresta - Crunchbase Company Profile & Funding
Acresta is a global software, technology and services provider with headquarters in Sydney, Australia and offices in Melbourne, Auckland, Singapore, the Philippines and Vietnam …See details»
Alcresta Therapeutics Announces Move to New Corporate …
Waltham, MA—December 5, 2022—Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today …See details»
Alcresta Company Profile - Office Locations, Competitors ... - Craft
Alcresta is a company developing and commercializing innovative enzyme-based nutritional products that support improved nutrition and manage the disease for infants, aging adults and …See details»
Working at Alcresta Therapeutics - Zippia
Mar 14, 2024 Alcresta's core capabilities include expertise in adult and pediatric nutrition, as well as protein manufacturing expertise and regulatory experience that support the development …See details»
VP Medical Affairs | Alcresta Therapeutics
Develop strategies that optimally manage KOL/academic institutions and other key health care provider/organization relationships, specifically with the provision of timely and up-to-date …See details»
Alcresta - Contacts, Employees, Board Members, Advisors & Alumni
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
Daniel Orlando - CEO at Alcresta Therapeutics | The Org
Daniel Orlando is the Chief Executive Officer of Alcresta Therapeutics. He joins the team with more than 18 years of executive management and corporate development experience leading …See details»
Linden Invests in Alcresta Therapeutics
Chicago, IL (March 12, 2024) – Linden Capital Partners (“Linden”), a Chicago-based healthcare private equity firm, announced today the completion of its acquisition of Alcresta Therapeutics, …See details»
Linden Capital Partners Acquires Alcresta Therapeutics, Inc.
Mar 12, 2024 Linden Capital Partners ("Linden"), a Chicago-based private equity firm focused exclusively on the healthcare industry, announced today the completion of its acquisition of …See details»
Contact | Alcresta Therapeutics
For more information about Alcresta Therapeutics, please contact us at: Alcresta Therapeutics, Inc. 130 Turner Street Building 3, Suite 200 Waltham, MA 02453 USA Email: [email protected] …See details»
Linden Capital Partners acquires Alcresta - Crunchbase
Mar 12, 2024 Alcresta Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases. Acquiring Organization: Linden Capital Partners …See details»
Alcresta Therapeutics Announces Publication of NASPGHAN …
Newton, M.A. – February, 23 2021 – Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today …See details»